Skip to Main Content

Paper Details

Novel histone deacetylase inhibitor N25 exerts anti-tumor effects and induces autophagy in human glioma cells by inhibiting HDAC3.
Oncotarget
8
2017
Atg1, Atg6, Beclin-1, HDAC3, LC3, N25, SAHA, Tip60, ULK1, anticancer, glioma, glioma cells, histone deacetylase, human, human glioma cells, normal, suberoylanilide hydroxamic acid, tumor
Author NameAffiliation
Holly LindsayPreclinical Neuro-Oncology Research Program, Texas Children's Cancer Center, Baylor College of Medicine
Holly LindsayPreclinical Neuro-Oncology Research Program, Texas Children's Cancer Center, Baylor College of Medicine
Sibo ZhaoPreclinical Neuro-Oncology Research Program, Texas Children's Cancer Center, Baylor College of Medicine
Xiao-Nan LiPreclinical Neuro-Oncology Research Program, Texas Children's Cancer Center, Baylor College of Medicine
  • 1 - 4

Datasets

Release 1.2